Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 31Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Nasopharyngeal Carcinoma 36Squamous Cell Carcinoma of Head and Neck 19Head and Neck Neoplasms 17Nasopharyngeal Neoplasms 7Salivary Gland Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Hypopharyngeal Neoplasms 2Gallbladder Neoplasms 2Bile Duct Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Spinocerebellar Degenerations 1Skin Neoplasms 1Neoplasms, Unknown Primary 1

Interventions

pembrolizumab 9Nivolumab 4Magnetic Resonance Spectroscopy 3spartalizumab 2Ipilimumab 2Gemcitabine 2Fluorodeoxyglucose F18 2FAPI-46 2Drug Therapy 2Cisplatin 2zenocutuzumab 1venetoclax 1ulixertinib 1trametinib 1tislelizumab 1seribantumab 1rovalpituzumab tesirine 1pazopanib 1neratinib 1margetuximab 1lenvatinib 1entrectinib 1durvalumab 1cobimetinib 1cemiplimab 1budigalimab 1bemarituzumab 1atezolizumab 1alectinib 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Capecitabine × Head & Neck × Clear all
NCT05007106 2025-08-14

KEYVIBE-005

Merck Sharp & Dohme LLC

Phase 2 Completed
613 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡